Employees: 11 (2023.0)Legal category: SCA (commandite par actions)Size: GECreation date: 2017-11-24 (8 years)Status: ActiveBusiness sector: Location de terrains et d'autres biens immobiliersLocation: NANTES (44300), Loire-Atlantique
EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE : revenue, balance sheet and financial ratios
EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE is a French company
founded 8 years ago,
specialized in the sector Location de terrains et d'autres biens immobiliers.
Based in NANTES (44300),
this company of category GE
shows in 2024 a revenue of 6.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE (SIREN 833684087)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
6 343 852 €
6 009 641 €
3 692 353 €
2 959 606 €
2 565 037 €
N/C
N/C
N/C
Net income
164 797 €
319 824 €
413 023 €
127 651 €
87 455 €
-13 782 €
-11 428 €
-1 300 €
EBITDA
473 170 €
522 798 €
261 756 €
141 104 €
107 844 €
-13 782 €
-11 428 €
-1 299 €
Net margin
2.6%
5.3%
11.2%
4.3%
3.4%
N/C
N/C
N/C
Revenue and income statement
In 2024, EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE achieves revenue of 6.3 M€. Over the period 2020-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +25.4%. Vs 2023: +6%. After deducting consumption (47 k€), gross margin stands at 6.3 M€, i.e. a rate of 99%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 473 k€, representing 7.5% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 165 k€, i.e. 2.6% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2024)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
6 343 852 €
Gross margin (2024)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
6 296 557 €
EBITDA (2024)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
473 170 €
EBIT (2024)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
249 545 €
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
164 797 €
EBITDA margin (2024)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
7.5%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 174%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 3.8 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 5.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
173.714%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
24.011%
Cash flow / Revenue (2024)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
5.725%
Repayment capacity (2024)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
3.774
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
0.0
0.0
0.0
30.992
17.122
182.474
155.288
173.714
Financial autonomy
74.0
58.227
18.895
38.601
38.372
24.915
26.886
24.011
Repayment capacity
0.0
0.0
0.0
1.004
0.586
9.819
3.5
3.774
Cash flow / Revenue
None%
None%
None%
3.882%
4.609%
4.19%
6.543%
5.725%
Sector positioning
Debt ratio
173.712024
2022
2023
2024
Q1: -20.62
Med: 5.98
Q3: 146.83
Average
In 2024, the debt ratio of EUROFINS LABORATOIRE NUTR... (173.71) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
24.01%2024
2022
2023
2024
Q1: 0.04%
Med: 27.47%
Q3: 73.82%
Average+6 pts over 3 years
In 2024, the financial autonomy of EUROFINS LABORATOIRE NUTR... (24.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
3.77 years2024
2022
2023
2024
Q1: -0.02 years
Med: 0.65 years
Q3: 10.57 years
Average-16 pts over 3 years
In 2024, the repayment capacity of EUROFINS LABORATOIRE NUTR... (3.77) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 202.13. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 17.7x. Operating income very largely covers interest expenses: high safety margin.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
202.132
Interest coverage (2024)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
17.743
Liquidity indicators evolution EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
384.615
239.387
123.356
223.181
188.792
202.175
204.142
202.132
Interest coverage
0.0
0.0
0.0
0.566
1.137
10.621
18.639
17.743
Sector positioning
Liquidity ratio
202.132024
2022
2023
2024
Q1: 83.33
Med: 307.99
Q3: 1318.25
Average
In 2024, the liquidity ratio of EUROFINS LABORATOIRE NUTR... (202.13) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
17.74x2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 20.04x
Good
In 2024, the interest coverage of EUROFINS LABORATOIRE NUTR... (17.7x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 64 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 26 days. The gap of 38 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 87 days of revenue, i.e. 1.5 M€ to permanently finance.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
1 531 913 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
64 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
26 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR in days of revenue (2024)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
87 j
WCR and payment terms evolution EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
640 951 €
786 545 €
1 633 202 €
1 515 151 €
1 531 913 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
Customer payment term (days)
0
0
0
48
55
77
62
64
Supplier payment term (days)
302
45
46
32
43
59
27
26
Positioning of EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE in its sector
Comparison with sector Location de terrains et d'autres biens immobiliers
Valuation estimate
Based on 169 transactions of similar company sales
in 2024,
the value of EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE is estimated at
3 084 569 €
(range 1 004 846€ - 5 634 815€).
With an EBITDA of 473 170€, the sector multiple of 5.6x is applied.
The price/revenue ratio is 0.81x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
169 transactions
1004k€3084k€5634k€
3 084 569 €Range: 1 004 846€ - 5 634 815€
NAF 5 année 2024
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
473 170 €×5.6x
Estimation2 649 670 €
701 385€ - 4 729 335€
Revenue Multiple30%
6 343 852 €×0.81x
Estimation5 117 126 €
1 955 416€ - 9 542 189€
Net Income Multiple20%
164 797 €×6.8x
Estimation1 122 981 €
337 645€ - 2 037 456€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 169 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Location de terrains et d'autres biens immobiliers)
Compare EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE with other companies in the same sector:
Frequently asked questions about EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE
What is the revenue of EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE ?
The revenue of EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE in 2024 is 6.3 M€.
Is EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE profitable?
Yes, EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE generated a net profit of 165 k€ in 2024.
Where is the headquarters of EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE ?
The headquarters of EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE is located in NANTES (44300), in the department Loire-Atlantique.
Where to find the tax return of EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE ?
The tax return of EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE operate?
EUROFINS LABORATOIRE NUTRITION ANIMALE FRANCE operates in the sector Location de terrains et d'autres biens immobiliers (NAF code 68.20B). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart